Results 161 to 170 of about 37,643 (291)

Neurovascular–metabolic dysregulation, metabolic connectomics, and metabolic functional changes in Alzheimer's disease: A preclinical and clinical comparison

Alzheimer's &Dementia, Volume 22, Issue 5, May 2026.
Abstract Historically, imaging diagnostics in Alzheimer's disease (AD) have focused primarily on amyloid and tau accumulation; however, recent work suggests that neurometabolic and vascular dysregulation (MVD) may precede protein deposition and persist throughout the disease spectrum, preclinically and clinically.
Juan Antonio K. Chong Chie, Scott A. Persohn, Olivia R. Simcox, Alyssa Collins, Paul Salama, Paul R. Territo, for the Alzheimer's Disease Neuroimaging Initiative and MODEL‐AD consortium   +6 more
wiley   +1 more source

Retraction Note: MCM-41 supported 2-aminothiophenol/Cu complex as a sustainable nanocatalyst for Suzuki coupling reaction. [PDF]

Sci Rep
Bibak S, Poursattar Marjani A, Sarreshtehdar Aslaheh H.   +2 more
europepmc   +1 more source

Design of Nanostraws in Amine-Functionalized MCM-41 for Improved Adsorption Capacity in Carbon Capture. [PDF]

Energy Fuels, 2023
Ajumobi O, Wang B, Farinmade A, He J, Valla JA, John VT.   +5 more
europepmc   +1 more source

Impact of Physical Frailty on Early Intolerance to CAPOX Chemotherapy in Patients With Colon, Rectal, and Gastric Cancer

Cancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Background Patients with gastrointestinal cancer often present reduction in functional capacity and develop frailty, which increases the risk of chemotherapy intolerance. We investigated whether physical frailty is associated with early intolerance to CAPOX (capecitabine+oxaliplatin) in patients with colon, rectal, or gastric cancer.
Isabella Pellegrini Grama Pereira Lima, Nicolle Martins Carrozzi, Talita Oliveira Silva, Karina Almeida de Brunheroti, Joyce Lucchesi, Andréia Cristina Dalbello Rissati, Lucinea Valério de Almeida Castro, Maria Carolina Santos Mendes, José Barreto Campello Carvalheira, Lígia M. Antunes‐Correa   +9 more
wiley   +1 more source

Inside the Framework: Structural Exploration of Mesoporous Silicas MCM-41, SBA-15, and SBA-16. [PDF]

Materials (Basel)
Karczmarska A, Laskowska W, Stróż D, Pawlik K.   +3 more
europepmc   +1 more source

Evidence of Strong Guest-Host Interactions in Simvastatin Loaded in Mesoporous Silica MCM-41. [PDF]

Pharmaceutics, 2023
Cordeiro T, Matos I, Danède F, Sotomayor JC, Fonseca IM, Corvo MC, Dionísio M, Viciosa MT, Affouard F, Correia NT.   +9 more
europepmc   +1 more source

Catalytic Transfer Hydrogenation Reactions of Glycerol Over Zr‐Incorporated Zeolite Beta Prepared by a Mechanochemical Approach

ChemCatChem, Volume 18, Issue 9, 14 May 2026.
Metal‐modified beta zeolite has long been recognized as an important catalyst for reactions involving acid and bifunctional catalysis. The gas‐phase conversion of glycerol over Zr‐beta (prepared by a mechanochemical approach) demonstrated the remarkable versatility of this catalytic system, evidenced by the production of glycerol hydrogenolysis ...
Auguste Fernandes, M. Filipa Ribeiro, João P. Lourenço   +2 more
wiley   +1 more source

Structural Characterizations of MCM-41 Synthesized from Coal Gasification Slag: Effect of Metal Impurities. [PDF]

ACS Omega
Yao S, Du W, Chen C, Pan Y, Meng W, Zhang Z, Zhang H, Tian Q.   +7 more
europepmc   +1 more source

Micro–Mesoporous Ferrierite: Strategies for Tuning the Accessibility of a Peculiar Zeolite

ChemCatChem, Volume 18, Issue 10, 27 May 2026.
The anisotropic structure of ferrierite (FER) zeolite makes challenging the increase of catalyst effectiveness by hierarchical porosity. The pore mouth location of the active sites for butene isomerization requires a fine balance between development of external surface and retention of shape selectivity.
Jonathan Fabian Sierra‐Cantor, Francesco Di Renzo, Nathalie Tanchoux, Corine Gérardin   +3 more
wiley   +1 more source

Preparation and properties study of self-healing anticorrosive coating based on MCM-41 nanocontainer and triazinyl corrosion inhibitor. [PDF]

Sci Rep
Cao G, Ruan Y, Liu J, Hu Z, Zhu H.
europepmc   +1 more source